Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

This study has been completed.
Information provided by (Responsible Party):
Genentech, Inc. Identifier:
First received: November 12, 2004
Last updated: March 19, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2004
  Estimated Primary Completion Date: No date given